Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2025	Jun. 30, 2025
Current assets
Cash and cash equivalents	$ 166	$ 167
Receivables, net	703	821
Inventories, net	577	523
Prepaid expenses and other current assets	249	97
Total current assets	1,695	1,608
Property, plant and equipment, net of accumulated depreciation and amortization of $2,955 and $2,911, respectively	1,251	1,267
Operating lease right-of-use assets	318	333
Goodwill	1,227	1,229
Trademarks, net	502	502
Other intangible assets, net	59	64
Other assets	476	558
Total assets	5,528	5,561
Current liabilities
Notes and loans payable	218	4
Current operating lease liabilities	89	87
Accounts payable and accrued liabilities	1,927	1,828
Total current liabilities	2,234	1,919
Long-term debt	2,485	2,484
Long-term operating lease liabilities	286	305
Other liabilities	365	351
Deferred income taxes	20	20
Total liabilities	5,390	5,079
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of September 30, 2025 and June 30, 2025; and 121,775,608 and 122,694,263 shares outstanding as of September 30, 2025 and June 30, 2025, respectively	131	131
Additional paid-in capital	1,326	1,319
Retained earnings	200	432
Treasury stock, at cost: 8,965,853 and 8,047,198 shares as of September 30, 2025 and June 30, 2025, respectively	(1,514)	(1,404)
Accumulated other comprehensive net (loss) income	(165)	(157)
Total Clorox stockholders’ (deficit) equity	(22)	321
Noncontrolling interests	160	161
Total stockholders’ equity	138	482
Total liabilities and stockholders’ equity	$ 5,528	$ 5,561